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Growth attenuation therapy (GAT) is a controversial intervention used to halt the 
growth of children with profound disability with the intention of facilitating long-term 
care by the child’s guardians. There are no nationally accepted clinical guidelines to 
direct clinicians how and under what circumstances to initiate a referral for GAT, and 
clinician attitudes and practices regarding GAT are poorly understood. Pediatric genetic 
counselors often serve a role helping guardians make decisions about treatments and 
coordinating care for their child.  In this study, genetic counselor attitudes and clinical 
behaviors regarding GAT were explored through a survey of 62 pediatric genetic 
counselors and semi-structured interviews with eight genetic counselors who had 
considered or discussed GAT for a patient. GAT is a divisive intervention for genetic 
counselors, and attitudes toward GAT diverged the most regarding the degree to which 
GAT infantilizes children and the extent to which choosing GAT for a profoundly 
disabled child infringes on that child’s autonomy. Most genetic counselors felt some 
discomfort about discussing GAT with a family whether due to their limited knowledge 
of the intervention or their opposition to its use. However, participants also emphasized 
genetic counselors’ unique skillset as a bridge between medical doctors and patients, and 
as a source of therapeutic counseling for guardians facing difficult care decisions which 
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  Growth attenuation therapy (GAT) is a medical intervention by which the growth 
of a child may be arrested at a young age using an oral, injected, or patch-delivered estrogen 
supplement (Venn et al., 2008). In the past decade, this treatment has received attention as 
a way to facilitate independent care for guardians of non-ambulatory children with severe 
physical and cognitive delays. First reported in 2006, the use of GAT to halt the growth of 
a six-year-old girl with profound cognitive and physical disability was estimated to reduce 
her adult height by 25.4 cm (Gunther & Diekema, 2006). Venn and colleagues have 
reported that GAT has no effect on those who undergo treatment at a bone age of 15 or 
older, and that greatest height reductions occur when guardians decide whether their child 
will undergo GAT by the time they are 10 years old (2008). Among medical professionals, 
ethicists, legal professionals, and guardians, GAT raises a debate over such issues as 
quality of life, autonomy, and human dignity. Proponents write that growth attenuation, 
sometimes paired with hysterectomy and/or breast bud removal, is a way to help aging 
guardians care for their children as they grow without the need for outside or institutional 
care (Diekema & Frost, 2010; Kerruish, 2016). Supporters emphasize an improved quality 
of life associated with GAT: if a child’s growth is halted, they are easier to carry, change, 
bathe, and bring on vacations, and they may never need a stranger to take care of them 
regularly.  
  The American Association on Intellectual and Developmental Disabilities took a 
strong stance against GAT, renaming it “ethics-attenuation intervention” for the purposes 
of their position statement (Bersani, et al., 2007). Critics of GAT warn that its use 
infantilizes the treated children, harkening to an age of eugenics and human rights 
violations of those with intellectual disability. From this perspective, GAT violates the 
2 
 
autonomy and dignity of children for the purpose of easing the burden on the guardians but 
has no clear benefit to the children themselves (Ouellette, 2009). Similar concerns have 
arisen in debate about other interventions intended to ease care and increase quality of life 
for children with profound disability, such as sterilization, breast bud removal, and 
restricting weight to the low end of healthy through diet (Cureton & Silvers, 2017; Diekema 
& Frost, 2010). These interventions have a longer history of study and research than GAT, 
and GAT’s use is complicated by the fact that sometimes interventions such as sterilization 
and breast bud removal are implemented in conjunction with growth attenuation.  
Critics also express concern about GAT’s unknown efficacy and side effects when 
used for young children, and that its use amounts to an experimental medical procedure on 
disabled children who cannot consent (Brosco & Feudtner, 2006). Follow-ups with healthy 
women who were historically treated for tall stature as adolescents revealed no significant 
long-term side effects from GAT However, there is a known risk for short-term pain and 
thrombosis, and any additional risks based on treating at a younger age are unknown (Pyett 
et al., 2005). Given its only recent use for children with profound disability, there has not 
been the opportunity for a longitudinal comparison of treated and untreated children in 
categories such as overall health, quality of life, and length living at home under the care 
of their guardians. These knowledge gaps have contributed to the controversy surrounding 
this potential intervention. 
GAT in the medical community 
  Currently, there are no nationally accepted clinical guidelines that outline the 
process by which medical professionals should discuss GAT with guardians, in which cases 
GAT is appropriate or inappropriate, and how treatment should progress. Furthermore, 
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professional societies such as the American Academy of Pediatrics, the American 
Association of Clinical Endocrinologists, and the American College of Medical Genetics 
and Genomics have demurred from publishing position statements. Clinicians continue to 
field questions and requests for GAT without guidance, and it is likely that these 
discussions will become more frequent as GAT becomes more well-known to both 
guardians and clinicians.  
  In a survey of 284 American pediatric endocrinologists, approximately one in three 
respondents had been asked about GAT by parents of children with profound physical and 
cognitive disability, and approximately one in ten respondents had prescribed GAT 
(Pollock et al., 2015). There have been no formal surveys of American pediatricians, 
endocrinologists, geneticists, or genetic counselors that assess attitudes toward GAT and 
how those attitudes affect the ways in which medical professionals discuss, prescribe, and 
facilitate the treatment.   
  Independent commentaries provide some insight into the attitudes of medical 
professionals toward GAT. Some pediatricians in the United States and New Zealand have 
recommended that a discussion of GAT be initiated by the child’s practitioner as 
anticipatory guidance for one of many treatments that some guardians may wish to consider 
(Allen et al., 2009; Wrigley et al., 2017). Other medical professionals have made 
statements decrying GAT as an inappropriate and unethical therapy for children with 
profound disabilities (Tan & Brassington, 2017). In one study of medical professionals 
from New Zealand, approximately the same number of respondents believed that GAT was 
an inappropriate therapy for children with profound physical and cognitive disabilities as 
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those who felt that GAT should be offered to all guardians of children with those 
disabilities (Wrigley et al., 2017).  
  Due to the starkly contrasting attitudes toward GAT, developing a comprehensive 
position statement or clinical guideline proves difficult. In 2010, a report was published of 
a 20-person working group formed to deliberate the ethical and policy considerations 
associated with GAT (Wilfond et al.). This diverse group of professionals included experts 
in medicine, law, bioethics, and philosophy, as well as multiple individuals who were either 
personally affected by significant disability or had family members with a profound 
disability. Ultimately, no consensus was reached, but instead the group presented a “moral 
compromise”: GAT is acceptable in some circumstances, but should be preempted with a 
structured decision-making process, meeting set eligibility criteria, and the involvement of 
an ethics committee. The specific format for these processes was not specified, but a 
preliminary guideline for eligibility criteria was suggested: appropriate candidates would 
be both non-ambulatory and non-communicative, and the condition must be presumed to 
be permanent.  These suggested guidelines were not satisfactory to all members of the 
working group, but they are generally in line with the suggested guidelines for similarly 
controversial treatments such as sterilization of minors with profound disability 
(Committee on Bioethics, 1999; Paransky & Zurawin, 2003). Whether genetic counselors 
are aware of the results of this working group or if their practice is influenced by it remains 






Genetic counselors and GAT 
  As genetic testing technologies advance – particularly whole exome sequencing –, 
geneticists and genetic counselors may become a more common part of the care team for 
families seeking a diagnosis. It is likely that genetic clinicians who disclose diagnostic and 
prognostic information to guardians will begin to face questions about GAT more often 
(Kuperberg et al., 2016). Genetic counselors have the potential to play many roles for a 
family affected by disability. They may see the same client annually or more frequently, 
participate in care coordination, and serve as a bridge between the families and their 
medical team. Genetic counselors in the pediatric setting generally work in tandem with a 
pediatric geneticist, and although the genetic counselors themselves may not sign off on 
referrals, their unique relationship with the family and the physician has the potential to 
impact care. A genetic professional’s attitude toward and mode of addressing the option of 
GAT may influence the decision-making process for the options available to guardians and 
their children.  
  In a 2007 study of how religion and conscience inform clinical practice surrounding 
controversial treatments, 14% of responding physicians reported that they would not 
inform patients of all legal medical options if the physician opposed one or more of the 
options on moral grounds, and 29% of responding physicians reported that they would not 
refer patients to a physician who would provide a controversial service with which they 
were opposed (Curlin, et al.).  
  Genetic counselors are known to at times face moral value conflicts with clients. 
However, much of the research into how genetic counselors manage these conflicts focuses 
on the prenatal setting, where decisions about morally-laden options such as prenatal 
6 
 
genetic testing, sex-selection, and termination are common (Silver et al., 2007). Genetic 
counseling as a field was founded on the concept of non-directiveness, which espouses 
separating one’s personal values from professional work (Clarke, 2017). If subscribed to, 
non-directiveness suggests that a genetic counselor’s attitudes toward controversial 
medical options should not affect the way they discuss those options and referrals with 
clients. In a series of interviews with 34 genetic counselors on the controversial topic of 
terminating a healthy pregnancy due to the fetus’ sex, most genetic counselors would refer 
clients to resources or discuss this option despite their personal feelings on the morality of 
the practice. Other responses to this request from clients included the genetic counselor 
voicing her objections to the practice, refusing to refer based on institutional guidelines, or 
requesting that a different counselor work with the couple (Burke, 1992).  
A recent survey of genetic counselors regarding non-medical sex selection through 
pre-implantation genetic diagnosis technology revealed that although most genetic 
counselors did not support this practice and felt discomfort discussing the option, in 
practice they supported the right of couples to use this technology for any reason (Yu, 
2015).  Respondents to Yu’s survey also indicated concerns about the role of genetic 
counselors in discussing these options, which suggests a desire for guidelines at an 
institutional or national level. One function of the present study is to assess if there is a 
perception of a similar need among genetic counselors for guidelines regarding GAT. 
  A genetic counselor’s perspective on the ethics of a practice has the potential to 
affect the care that a client receives, but it is unclear how or to what extent conversations 
about GAT may be influenced by how genetic counselors feel about GAT. How genetic 
counselors view and conduct discussions about GAT is particularly interesting as genetic 
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counselors have unique education in understanding the decision-making and adaptation 
process for families affected by disability. Genetic counselors frequently serve as care 
coordinators and patient advocates and may have unique contributions to the ethics 
discussion surrounding GAT. Understanding how genetic counselors approach GAT will 
provide a clearer picture of how these conversations are conducted in the pediatric genetics 
setting. The role that genetic counselors have in the pediatric setting regarding treatment 
and whether genetic counselors’ attitudes toward GAT affect their willingness to discuss 
the option may have direct impacts on the accessibility of GAT for families.  Genetic 
counselors are also likely to have insight into practices or guidelines regarding GAT that 
are followed by their teams and institutions that may affect referrals to GAT. 
 Conceptual Frameworks: The Four Topics and the Zone of Parental Discretion 
 Four principles of biomedical ethics underlie ethical decision making in medicine: 
beneficence, non-maleficence, justice, and autonomy (Beauchamp, 2013). Based on these 
principles, Schumann and Alfandre developed the Four Topics approach to clinical 
decision making (2008). Using this approach, clinicians are recommended to consider four 
broad topics which offer a series of specific considerations whose answers depend on the 







Topic Principles Sample Questions Additional GAT 
Questions 
Medical Indications Beneficence 
Non-maleficence 
• What is the diagnosis and 
prognosis? 
• What are the goals of 
treatment? 
• What are the 
probabilities of success? 
• What are the plans in 
case of therapeutic 
failure? 
• How severe are the 
child’s disabilities? 
• To what degree might 
adult height be reduced? 
• What are possible side 
effects, and what is the 
likelihood of those side 
effects? 
Quality of Life Beneficence 
Non-maleficence 
Autonomy 
• What physical, mental, 
and social deficits is the 
patient likely to 
experience from the 
treatment? 
• What are the prospects, 
with or without 
treatment, for a return to 
normal life? 
• Is the patient’s present or 
future condition such that 
their continued life might 
be judged as undesirable?  
• Are there biases that 
might prejudice the 
provider’s evaluation of 
quality of life? 
 
• How might the child’s 
life and/or care be 
affected by their 
expected adult height? 
• How might the child’s 
life and/or care be 
affected by GAT 
treatment? 
• Is there a plan in place 
for care if the family 
forgoes treatment? 
Contextual Features Justice • Are there family issues 
that might influence 
treatment options? 
• Are there religious or 
cultural factors? 
• Are there problems of 
allocation of resources? 
• How does the law affect 
treatment decisions? 
• How have the guardians 
talked about the use of 
GAT? What are their 
motivations? 
• What resources are 
available to the 
guardians to facilitate 
care? 
• Is clinical research a 
provider motivation for 
supporting GAT? 
Patient Preferences Autonomy • Is the patient mentally 
capable and legally 
competent? 
• Has the patient been 
informed of benefits and 
risks? 
• Has the patient expressed 
prior preferences (eg, 
advance directives)? 
• How are the child’s 
guardians managing the 
decision-making 
process? 
• To what extent are the 
guardians incorporating 
the child’s needs into 
the decision-making 
process? 
•  Are the child’s 
guardians  making the 
decision without undue 
outside pressure? 
Figure 1. The Four Topics approach to ethical decision making in medicine. 
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 Even after thoroughly addressing all four topics, clinicians may disagree about the 
weight that should be placed on the values captured by the questions. The ultimate decision 
about whether to assist in initiating GAT is unlikely to be with a genetic counselor alone. 
Certainly, the geneticist with whom the counselor works is likely to be involved in any 
discussion of GAT, and there may be a larger team, pediatric endocrinologist, or an ethics 
committee involved in cases in which guardians desire GAT but clinicians are unsure. 
These teams are faced with determining if the guardian’s wishes should be denied. 
 One recent tool put forth to help clinicians assess whether a denial is appropriate is 
the Zone of Parental Discretion (Gillam, 2016). Rather than attempting to determine the 
course of action that is in the child’s “best interests,” which can be nebulous as it is 
perceived differently be different individuals, Gillam asserts that clinicians should strive 
only to determine whether the course desired by parents or guardians would be harmful to 
the child. Gillam defines “harm” in the context of this tool as any “serious setback of 
interests,” which include components of well-being such as continued life, freedom from 
pain, relationships with others, and experience of happiness. The Zone of Parental 
Discretion acknowledges that at times the options available to a child and their family may 
all be sub-par, but any decision that does not harm the child – even if it is not considered 
the “best” course of action by clinicians – is permissible. This tool still leaves room for 
interpretation about the meaning of “harm,” and “serious”, however. As a result, two 
clinicians using the Zone of Parental Discretion may come to two different conclusions 
about whether GAT is appropriate for a child. 
 Because there are no national guidelines for addressing requests for GAT, clinicians 
such as genetic counselors may refer or deny referrals for GAT based on the dictates of 
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their own moral frameworks. It remains unclear, however, how genetic counselors 
conceptualize the ethics of GAT, if there is pressure from their field or institutions to 
support or reject GAT, or if they even view the discussion of GAT for children with 
profound disability as an ethically distressing event. 
Significance 
  Given the conflicting views on the ethics of GAT for children with profound 
disability, clinicians faced with helping families navigate the decision-making process 
would likely benefit from health organizations and institutions developing guidelines for 
its use. Establishing guidelines with which all stakeholders largely agree has proven 
difficult. Until guidelines are developed, clinicians must use their own judgement to 
determine procedures for assessing when GAT may be appropriate for children with 
profound disability.  
  Genetic counselors have a unique medical perspective in that they spend 
significant amounts of time with families in the pediatric setting, serving as patient 
advocates, care coordinators, and as counselors to facilitate decision-making and 
adaptation in families affected by disability. As genetic technologies advance, it may 
become more common for genetic counselors to face the task of informing guardians that 
genetic analysis predicts that their child with profound mental and physical disability will 
never learn to walk, speak, or feed themselves. As knowledge of GAT grows, more 
guardians are likely to consider its use as a way to independently care for their child for 
as long as possible. It is likely that genetic counselors will face more discussions about 
GAT in the near future as guardians become familiar with GAT and as exome sequencing 
technology increases in use. Understanding genetic counselors’ perspectives on the 
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practice will lend insight into how these discussions take place and how they may take 
place in the future. The purpose of this study was to understand the extent to which 
genetic counselors are aware of and participate in conversations surrounding GAT, as 
well as their attitudes toward the use of GAT and other controversial interventions in the 
pediatric setting. This study also assessed genetic counselors’ interest in guidelines 
regarding counseling for controversial interventions, and what would be useful to include 
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  Growth attenuation therapy (GAT) is a medical intervention used to arrest the 
growth of a child at a young age using an oral, injected, or patch-delivered estrogen 
supplement (Venn et al., 2008). This treatment has received recent attention as a way to 
facilitate independent care for guardians of non-ambulatory children with severe physical 
and cognitive delays. First reported in 2006, the use of GAT to halt the growth of a six-
year-old girl with profound cognitive and physical disability was estimated to reduce her 
adult height by 25.4 cm (Gunther & Diekema, 2006). Venn and colleagues have reported 
that GAT has no effect on those who undergo treatment at a bone age of 15 or older, and 
that greatest height reductions occur when initiated before the age of 10 (2008). Among 
medical professionals, ethicists, legal professionals, and guardians, GAT raises a debate 
over such issues as quality of life, autonomy, and human dignity.  
  Proponents write that growth attenuation, sometimes paired with hysterectomy 
and/or breast bud removal, is a way to help aging guardians care for their growing children 
without outside or institutional care (Diekema & Frost, 2010; Kerruish, 2016). Supporters 
the opportunity to improve quality of life: if a child’s growth is halted, they are easier to 
carry, change, bathe, and bring on vacation, and they may never need a stranger to take 
care of them regularly.  
Critics warn that GAT infantilizes the treated children, harkening to an age of 
eugenics and human rights violations of the intellectually disabled. From this perspective, 
GAT violates the autonomy and dignity of children for the purpose of easing the burden 
on the guardians without any clear benefit to the children themselves (Ouellette, 2009). 
Critics also argue that there remains a paucity of data about the efficacy and side effects of 
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GAT in this population, without which its use amounts to an experimental medical 
procedure on disabled children who cannot consent (Brosco & Feudtner, 2006). Follow-
ups with healthy women who were treated for tall stature as adolescents revealed no 
significant long-term side effects from GAT. However, there is a known risk for short-term 
pain and thrombosis, and any additional risks of treating at a younger age are unknown 
(Pyett et al., 2005). Though GAT proponents argue that there may be benefit to overall 
health, quality of life, and length living with guardians at home, ongoing knowledge gaps 
contribute to the controversy surrounding GAT. Similar concerns have arisen in debate 
about other interventions intended to ease care and increase quality of life for profoundly 
disabled children, such as sterilization, breast bud removal, and restricting weight to the 
low end of healthy through diet (Cureton & Silvers, 2017; Diekema & Frost, 2010). These 
interventions have a longer history of study and research than GAT, and GAT’s use is 
complicated by the fact that sometimes interventions such as sterilization and breast bud 
removal are implemented in conjunction with growth attenuation.  
GAT in the medical community 
  Currently, there are no nationally accepted clinical guidelines that outline the 
process by which medical professionals should discuss GAT with guardians, in which cases 
GAT is appropriate or inappropriate, and how treatment should progress. Furthermore, 
professional societies such as the American Academy of Pediatrics, the American 
Association of Clinical Endocrinologists, and the American College of Medical Genetics 
and Genomics have demurred from publishing position statements. Clinicians continue to 
field questions and requests for GAT without guidance, and it is likely that these 
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discussions will become more frequent as GAT becomes more well-known to both 
guardians and clinicians.  
  In a survey of 284 American pediatric endocrinologists, approximately one in three 
respondents had been asked about GAT by parents of children with profound physical and 
cognitive disability, and approximately one in ten respondents had prescribed GAT 
(Pollock et al., 2015). There have been no formal surveys of American pediatricians, 
endocrinologists, geneticists, or genetic counselors that assess attitudes toward GAT and 
how those attitudes affect the ways in which medical professionals discuss, prescribe, and 
facilitate the treatment.   
  Independent commentaries by American clinicians and research from outside the 
United States provide some insight into the attitudes of medical professionals toward GAT. 
Some pediatricians have recommended that a discussion of GAT be initiated by the child’s 
practitioner as anticipatory guidance for one of many treatments that some guardians may 
wish to consider (Allen et al., 2009; Wrigley et al., 2017). Other medical professionals have 
made statements decrying GAT as an inappropriate and unethical therapy for children with 
severe physical and cognitive disabilities (Tan & Brassington, 2017). In one study, 
approximately the same number of respondents believed that GAT was an inappropriate 
therapy for children with profound physical and cognitive disabilities as those who felt that 
GAT should be offered to all guardians of children with those disabilities (Wrigley et al., 
2017).  
  Due to the starkly contrasting attitudes toward GAT, developing a comprehensive 
position statement or clinical guideline proves difficult. In 2010, a report was published of 
a 20-person committee formed to deliberate the ethical and policy considerations 
16 
 
associated with GAT (Wilfond et al.). This diverse group of professionals included experts 
in medicine, law, bioethics, and philosophy, as well as individuals and family members of 
individuals affected by significant disabilities. Ultimately, no consensus was made, but 
instead a “moral compromise”: GAT is acceptable in some circumstances, but should be 
preempted with a structured decision-making process, meeting set eligibility criteria, and 
the involvement of an ethics committee. The format for these processes was not specified, 
but a preliminary guideline for eligibility criteria was suggested: appropriate candidates 
would be both non-ambulatory and non-communicative and their condition presumed to 
be permanent.  These suggested guidelines were not satisfactory to all members of the 
working group, but generally align with guidelines for similarly controversial treatment 
such as sterilization of minors with profound disability (Committee on Bioethics, 1999; 
Paransky & Zurawin, 2003). Whether genetic counselors are aware of the results of this 
working group or if their practice is influenced by it remains unknown. 
Genetic counselors and GAT 
  As genetic testing technologies advance - particularly whole exome sequencing – 
it is likely that geneticists and genetic counselors who disclose diagnostic and prognostic 
information to guardians will begin to face questions about GAT more often (Kuperberg 
et al., 2016). Genetic counselors play an important role for families affected by disability, 
since they see the same client annually or more frequently, participate in care coordination, 
and serve as a bridge between families and their medical team. A genetic professional’s 
attitude toward and mode of addressing the option of GAT may influence decision-making 
process for the options available to guardians and their children.  
17 
 
  Genetic counselors have unique education about the decision-making and 
adaptation process for families affected by disability. They frequently serve as care 
coordinators and patient advocates and may have unique contributions to the ethics 
discussion surrounding GAT. Understanding how genetic counselors view GAT will 
provide a clearer picture of how these conversations are conducted in the pediatric genetics 
setting.  
Conceptual Frameworks: The Four Topics and the Zone of Parental Discretion 
 Four principles of biomedical ethics underlie ethical decision making in medicine: 
beneficence, non-maleficence, justice, and autonomy (Beauchamp, 2013). Based on these 
principles, Schumann and Alfandre developed the Four Topics approach to clinical 
decision making (2008).  This approach encourages clinicians to approach ethical issues 
by developing four topics that can be broken down into specific questions that can be 










Topic Principles Sample Questions Additional GAT 
Questions 
Medical Indications Beneficence 
Non-maleficence 
• What is the diagnosis and 
prognosis? 
• What are the goals of 
treatment? 
• What are the 
probabilities of success? 
• What are the plans in 
case of therapeutic 
failure? 
• How severe are the 
child’s disabilities? 
• To what degree might 
adult height be reduced? 
• What are possible side 
effects, and what is the 
likelihood of those side 
effects? 
Quality of Life Beneficence 
Non-maleficence 
Autonomy 
• What physical, mental, 
social deficits is the 
patient likely to 
experience from the 
treatment? 
• What are the prospects, 
with or without 
treatment, for a return to 
normal life? 
• Is the patient’s present or 
future condition such that 
their continued life might 
be judged as undesirable?  
• Are there biases that 
might prejudice the 
provider’s evaluation of 
quality of life? 
 
• How might the child’s 
life and/or care be 
affected by their 
expected adult height? 
• How might the child’s 
life and/or care be 
affected by GAT 
treatment? 
• Is there a plan in place 
for care if the family 
forgoes treatment? 
Contextual Features Justice • Are there family issues 
that might influence 
treatment options? 
• Are there religious or 
cultural factors? 
• Are there problems of 
allocation of resources? 
• How does the law affect 
treatment decisions? 
• How have the guardians 
talked about the use of 
GAT? What are their 
motivations? 
• What resources are 
available to the 
guardians to facilitate 
care? 
• Is clinical research a 
provider motivation for 
supporting GAT? 
Patient Preferences Autonomy • Is the patient mentally 
capable and legally 
competent? 
• Has the patient been 
informed of benefits and 
risks? 
• Has the patient expressed 
prior preferences (eg, 
advance directives)? 
• How are the child’s 
guardians managing the 
decision-making 
process? 
• To what extent are the 
guardians incorporating 
the child’s needs into 
the decision-making 
process? 
•  Are the child’s 
guardians  making the 
decision without undue 
outside pressure? 
Figure 2. The Four Topics approach to ethical decision making in medicine. 
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 Even after addressing all four topics, clinicians may disagree about the weight 
placed on the values captured by the questions. The ultimate decision about whether to 
initiate GAT will involve a team including not only the genetic counselor and guardians, 
but also a geneticist, endocrinologist, and ethics committee.  
The Zone of Parental Discretion (Gillam, 2016) is a tool recently developed to help 
such teams simplify decisions about when to deny the medical requests of guardians. Since 
determining the course that would be in the child’s’ “best interest” is both nebulous and 
personal, Gillam asserts that clinicians should strive only to determine whether the course 
desired by guardians would be harmful to the child. ”Harm” is defined as a “serious setback 
of interests,” including components of well-being such as continued life, freedom from 
pain, relationships with others, and experience of happiness. The Zone of Parental 
Discretion acknowledges that at times the options available to a child and their family may 
all be sub-par, but any decision that does not harm the child – even if it is not considered 
the “best” course of action by clinicians – is permissible. This tool leaves room for 
interpretation as to the meaning of “harm,” and “serious”, however, so clinicians using the 
Zone of Parental Discretion may come to different conclusions about whether GAT is 
appropriate for a child. 
Significance 
 Because there are no national guidelines for addressing requests for GAT, clinicians 
may refer or deny referrals for GAT based on the dictates of their own moral frameworks. 
It remains unclear, however, how genetic counselors conceptualize the ethics of GAT, if 
there is pressure from their field or institutions to support or reject GAT, or if they even 
view the discussion of GAT for children with profound disability as an ethically distressing 
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event. Given genetic counselors’ role as advocates, care-coordinators, and facilitators of 
the decision-making process, it is important to clarify their roles and needs as discussions 






















 The target population for this study was pediatric genetic counselors with at least one 
year of experience. This population was chosen to capture the current understanding of and 
experience with GAT by those who may facilitate a referral, and to get a better 
understanding of the frequency with which this topic is discussed in pediatric genetic 
counseling sessions. We excluded genetic counselors new to the pediatric field to assure 
that respondents have had extensive experience working with guardians who have the 
concerns one might consider when thinking about GAT, such as quality of life and long-
term care.  
Instrumentation and Procedures 
 An electronic survey was developed using Qualtrics and was distributed to 
members of the National Society of Genetic Counselors (NSGC) via the NSGC email 
listserv. All participants were asked to share demographic information, their familiarity 
with GAT (“Are you familiar enough with GAT that you could describe its use to a 
colleague?”), and where they had heard of the intervention. The survey included a brief 
explanation of GAT for the participants to read, which included the primary arguments 
for and against its use. Respondents were then asked to share whether they personally 
support the use of GAT for children with profound disability, and to rate the extent to 
which the major arguments for and against GAT played a role in their opinion toward it. 
Semantic differential questions asked participants to rate GAT on the classical ethical 
tenants (beneficence, non-maleficence, autonomy, and justice) as well as its potential to 
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improve quality of life for child and guardian. A 5-point Likert scale was used to collect 
responses regarding genetic counselors’ beliefs about how GAT would be addressed by 
them in clinical practice, as well as how they believe it should be addressed as a field. 
Respondents were asked if they had discussed GAT with a guardian in their clinical 
practice; respondents with experience were asked to elaborate on the content of that 
counseling, including the age and indication of the child, who initiated the conversation 
about GAT, and if a final decision was made about whether to pursue GAT. Respondents 
were also asked about their experience and attitude toward other controversial 
interventions considered in the pediatric setting: sterilization, breast bud removal, and 
diet restriction to maintain low weight. Finally, participants were asked about the 
perceived utility of a hypothetical guideline or position statement regarding how to 
counsel about controversial interventions. Open-ended, text-entry questions throughout 
gave participants the opportunity to elaborate on their answers. Respondents were offered 
the opportunity to elaborate on multiple choice questions such as their support or 
opposition to GAT and the other interventions and to elaborate on their interest in a 
guideline or position statement. The portion of the survey detailing personal experience 
with counseling for GAT included a text box to add any additional information that was 
important to their counseling. 
 Survey respondents who reported experience considering GAT for a child with 
profound disabilities were invited to participate in a semi-structured telephone interview 
about the content of the counseling involved, how their perception of GAT has changed 
overtime, and under what circumstances GAT is acceptable to them. Participants were 
also asked more broadly about how they decide whether to support or counsel against a 
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guardian’s choice for a child, and what would be useful to include in guidelines regarding 
controversial interventions such as GAT, sterilization, breast bud removal, and diet 
restriction. Additional genetic counselors with experience considering GAT for a patient 
were recruited for an interview with follow-up emails through the NSGC listserv as well 




 Survey data were downloaded from Qualtrics and analyzed using Excel 2016 and 
R Studio with R 3.4.3. Variables were subjected to univariate, descriptive analysis to 
calculate ranges, means, standard deviations, and frequencies. Due to the sample size, 
survey analysis was exploratory and descriptive in nature. A total of 54 text responses were 
reviewed for recurring themes and were able to be coded using the codes developed during 
the interview analysis. 
Interviews 
 Immediately post-interview, KA recorded her initial impressions of the major 
themes and notes for analysis. Major themes and analytic notes included the participant’s 
overall tone and attitude toward GAT, recurring comments made by the participant, and 
any statements which concisely captured their responses to the interview questions. 
Interviews were transcribed verbatim by Production Transcripts and checked for accuracy 
by KA. Transcripts of interviews were analyzed in MAXQDA using thematic analysis, 
which allows for the identification of common themes between transcripts. In accordance 
with the reliability and validity practices set forth by Morse and colleagues, the collection 
and analysis of data occurred concurrently, and creating the codebook was an iterative 
24 
 
process that continued throughout the interview and analysis process, with multiple rounds 
of coding as new concepts emerged (Morse, 1997; Morse et al., 2002). KA met with JO 
three times over the course of the analysis to review the interview and analysis process and 
resolve analytic challenges. 
Codes were developed inductively and deductively. Some codes were created based 
directly on questions in the interview guide. For example, KA asked all participants to 
describe a scenario in which GAT might be an appropriate intervention for a child. The 
code “When GAT is Appropriate” was created, as well as sub-codes to capture the 
responses given, such as “If Research-Backed” and “Only if Non-Ambulatory.” A code 
was created to capture the concept of the Zone of Parental Discretion, which was elicited 
with the question “How do you draw the line in what you would support a parent choosing 
on behalf of their child?” and follow-up questions such as “What characteristics of a child 
or family do you consider when deciding for whom an intervention is appropriate?” and 
“What characteristics of an intervention make it appropriate or inappropriate for a parent 
to choose on behalf of their child?” Novel codes were identified over the course of the 
interview based on participant-initiated discussion independent of questions specifically 
directed by the interview guide. For example, when participants described aspects of a 
pediatric appointment which they believe are more appropriately addressed by a physician 
than a genetic counselor, such as medication recommendations or even GAT itself, a code 
was created called “Outside Scope of Practice.” 
After all codes were created and all coding iterations were complete, existing codes 
were organized into the Four Topics themes (Medical Indications, Quality of Life, 
Contextual Features, and Patient Preferences). Codes and coded segments concerning how 
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the participant perceives GAT and its utility were grouped under their appropriate Four 
Topics theme. For example, under “Medical Indications,” codes and coded segments were 
listed in which the participant described the medical context in which they feel GAT is 























 A total of 91 genetic counselors responded to the survey; 62 were included in 
analysis because they both met inclusion criteria and completed questions beyond the 
demographic portion. Demographic characteristics are presented in Table 1. Respondents 
were mostly women (90.3%) and white (95%), with one participant identifying as 
American Indian or Native Alaskan and two identifying as Asian. Although lacking 
representation from participants identifying as black/African American or as native 
Hawaiian/Pacific Islander and Hispanic or Latino/a, these demographics mirror trends 
identified through the National Society of Genetic Counselors’ Professional Status 
Survey (PSS). The PSS revealed that responding genetic counselors were 95% women 
and 92% white, with 1% identifying as black or African American, less than 1% 
identifying as Hawaiian or Pacific Islander, and 2% identifying as Hispanic or Latino/a 
(2018). Over 85% of respondents were under the age of 40, compared to 70% in the PSS, 
and over half of respondents had 1-3 years of experience as a genetic counselor. 
Geographical representation mirrored the responses from the PSS for Regions 1-3, but 
region 4 was over-represented (45.2% compared to 28% in the PSS) and Regions 5 and 6 







Table 1. Participant demographics 
  
Characteristic Number (%) 
  
Gender  
Woman 56 (90.3) 
Man 5 (8.1) 
Other 1 (1.6) 
  
Race  
White 59 (95) 
American Indian or Alaska Native 1 (1.6) 
Asian 2 (3.2) 
Black or African American 0 
Native Hawaiian or Pacific Islander 0 
  
Spanish or Latino/a  




20-29 32 (51.6) 
30-39 21 (33.9) 
40-49 3 (4.8) 
50-59 6 (9.7) 
  
Years of Genetic Counseling Experience  
1-3 35 (56.5) 
4-8 12 (19.4) 
9-15 10 (16.1) 
16-20 1 (1.6) 
21-30 3 (4.8) 
31-40 1 (1.6) 
  
Years of Pediatric Genetic Counseling Experience  
1-3 37 (59.7) 
4-8 13 (21.0) 
9-15 9 (14.5) 
16-20 1 (1.6) 




Region 1 (CT, MA, ME, NH, RI, VT, CN, Maritime Provinces) 4 (6.5) 
Region 2 (DC, DE, MD, NJ, NY, PA, VA, WV, PR, VI, Quebec) 13 (21.0) 
Region 3 (AL, FL, GA, KY, LA, MS, NC, SC, TN) 7 (11.3) 
Region 4 (AR, IA, IL, IN, KS, MI, MN, MO, ND, NE, OH, OK, SD, WI, Ontario) 28 (45.2) 
Region 5 (AZ, CO, MT, NM, TX, UT, WY, Alberta, Manitoba, Sask) 4 (6.5) 
Region 6 (AK, CA, HI, ID, NV, OR, WA, British Columbia) 6 (9.7) 
 
Knowledge of GAT 
 When asked if they are familiar enough with GAT to describe its use to a 
colleague, 67.7% of respondents (42) answered ‘No.’ Participants who were familiar with 
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GAT were asked to select all the places from which they learned about the intervention 
(figure 3). Sources of information varied widely, with 4 respondents not remembering at 
least once source of information about GAT and an additional 8 not remembering where 
any of their knowledge of GAT came from. One respondent selected ‘other’ as their 
source of GAT knowledge, and in a text response clarified that they had heard of GAT in 
an undergraduate course. 
 
 
Personal Attitude Toward Controversial Interventions 
 Twenty-four respondents (38.7%) reported that they personally support GAT for 
use with profoundly disabled pediatric patients, while 16% opposed its use and 17% 
reported that they “cannot not say – I do not lean one way or the other.” Growth 


























Where have you heard about growth attenuation 
therapy? (n=57)
Figure 3. Sources of information about GAT. “Professional meeting” included 
ethics committee, case conference, educational sessions, etc. 
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Figure 4. Genetic counselors’ attitudes toward the interventions included in the study. The n for GAT was 57, while the 
n values for sterilization, breast bud removal, and diet restriction were 56. Sterilization was specified as “Sterilization 
(for children with otherwise healthy reproductive systems),” breast bud removal was presented as “Breast bud removal 
(for children with no health concerns related to breasts)” and diet restricted was, “Restricting diet to maintain weight 
on the low end of healthy.”   
Understanding Support and Opposition Toward GAT 
 Genetic counselors who support GAT weighed the arguments to support and 
oppose the intervention differently from genetic counselors who oppose GAT (Figure 5). 
For genetic counselors who support GAT, the primary reasons are that it helps guardians 
lift, move, and care for their child in other ways, it has the potential to increase family 
quality of life, and it makes long-term home care more feasible. For counselors who 
oppose GAT, the primary reasons are that the side effects are poorly understood, it 
infantilizes children into adulthood, and children cannot consent/assent. Supporting 






















Personal Attitude Toward Interventions
Support Cannot Say Oppose
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when forming their attitude toward GAT, and opposing genetic counselors were less 
likely to take into account the potential quality-of-life benefits such as longer home-care 
and involvement in vacations. 
 Eleven text responses elaborated on respondents’ stance toward GAT. Five text 
responses from genetic counselors who support GAT emphasized that it should be 
considered on a case-by-case basis, and that the decision to pursue GAT is a personal 
one. Some went on to say that they would not initiate conversations about GAT until the 
proposed benefits are confirmed: 
 
“I answered that I "lean toward supporting" GAT, but it is not something that I would 
provide as an option to my families at this point unless the family mentioned it first. I 
think there should be a great deal more research regarding side effects and QoL [quality 
of life] before it could be considered a standard offering in these types of cases.” 
 
 Genetic counselors who oppose GAT reinforced their disbelief in the proposed 
benefit for the child and emphasized that the suggested benefit for the caretakers is not 
sufficient for implementing the intervention: 
 
“I believe medical interventions should only be used to improve the health and quality of 





Figure 5. Arguments to support or oppose GAT, ranked by genetic counselors supporting GAT(S) and opposing GAT 





















































































































The side effects are unacceptable
It infantilizes individuals into adulthood
Easing a parent's burden is not
justification
It denies autonomy and dignity
It reflects societal tendency to view people
with disabilities as burdens
Children cannot consent/assent
No published studies confirm quality of
life increase
Side effects are poorly understood
Treating children by cognitive age is not
infantilization
It allows children to be more involved in
home life (vacations, etc)
Historically, side effects are rare
Parents have right to make health
decisions for children
It has the potential to increase child
quality of life
It makes long-term home care more
feasible
It has the potential to increase family
quality of life
It helps parents lift, move, and care for
their child in other ways
How much do these arguments play a role in your personal opinion of GAT for 
children with profound disability?
Not at all A little bit Moderately A lot
S: Genetic counselors supporting GAT


















































 Semantic differential questions assessed genetic counselors’ beliefs regarding 
how GAT interacts with the four basic ethical principles as well as the degree to which it 
impacts quality of life for guardians and affected children (figure 6). Responses from 
genetic counselors in all three attitude groups (supporting, cannot say, opposing) 
followed the same gross pattern except that supporting and opposing groups diverged in 
their belief about GAT’s beneficence and converged in their belief about its maleficence. 
Other notable differences in beliefs include that genetic counselors opposing GAT 
identified it as an intervention which decreases patient quality of life and is unjust, while 
those supporting GAT believe that it increases patient quality of life and is just. All 
groups reported that GAT increases parent quality of life, denies patient autonomy, and 
supports parent autonomy. In general, genetic counselors opposing GAT ranked the 
intervention lowest on these ethics measures and genetic counselors supporting GAT 
ranked it highest, with the cannot say/neutral group rating the intervention in between the 
ratings of the other two groups. Three exceptions were the ratings for GAT’s effect on 
parent quality of life and patient autonomy, for which the “cannot say/neutral” group 
aligned more closely with genetic counselors supporting GAT, and the rating for GAT’s 
effect on parent autonomy, for which the “cannot say/neutral” group aligned more closely 




Figure 6. Semantic differential responses from genetic counselors opposing GAT (n=16), supporting GAT (n=24), and 
those who felt neutral or could not say if they support or oppose GAT (n=17). 
Clinical Guidelines 
 Table 2 summarizes respondents’ interest in a guideline or position statement 
from NSGC about how to counsel for controversial interventions. Most respondents felt 
that a guideline or position statement would be beneficial and would reference a 
guideline or position statement to inform their clinical care. Nine respondents elaborated 
on their stance in text responses, all of whom either supported guidelines or reported that 
their utility would depend on their content.  Respondents suggested that useful guidance 
would include current published data on GAT’s risks and benefits as well as guidance 
surrounding psychosocial counseling for guardians who are considering GAT for their 
child. Participants who were unsure about the utility of a guideline or position statement 
emphasized the limited role that genetic counselors have when it comes to medical care 
decisions. These responses suggest a divide in both the perceived role of NSGC 
1 2 3 4 5
Is not beneficent
Is maleficent
Decreases patient quality of life











Increases patient quality of 
life







guidelines and position statements and the perceived role of genetic counselors 
themselves. Genetic counselors who are interested in a guidance from NSGC highlight 
the role of genetic counselors in therapeutic counseling of guardians who are in a 
situation which may lead them to consider shortening the adult height of their child and 
are interested in tools to help them better engage families in thinking about this option in 
relation to other options. Genetic counselors who see little utility in a guideline or 
position statement are those who highlight the medical aspect of GAT as an intervention 
and do not believe genetic counselors could use a guideline given the field’s limited 
scope in counseling for the genetic components of care. It may be that there is overlap 
between these two groups which is not captured by the text responses provided. 
 
Table 2. Utility of guidelines regarding controversial interventions 
   
  
Do you feel that the NSGC would benefit 
from drafting guidelines or position 
statements about how to counsel for topics 
such as GAT, sterilization, breast bud 
removal, etc.? 
Would you refer to an NSGC 
guidelines or position statements 
about how to counsel for these 
practices if they were available? 
Yes 39 45 
Not sure 9 6 
No 5 2 
It depends 3 3 
 
GAT in Clinical Practice 
 Eight genetic counselors reported discussing GAT with guardians, with a total of 
13 separate instances.  Table 3 summarizes the indications and referral decisions for the 
reported cases. For one session, the genetic counselor did not report the 
indication/symptoms of the child involved. In most sessions, the option of GAT was 
brought up by a parent or guardian. The exceptions were three sessions in which GAT 
was first brought up by either an endocrinologist or geneticist. Most cases, including 
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those for which a physician initiated the GAT discussion, involved children with 
profound intellectual and physical disability. Guardians were rarely referred to an 
endocrinologist to further discuss GAT, and in only one case did the genetic counselor 
report that the guardian(s) chose to pursue the intervention. In no cases was an ethics 
committee involved in decision-making. Of the genetic counselors who had discussions 
about GAT with caretakers, nine reported being supportive of GAT and five reported an 
ambivalent stance.  
 Genetic counselors elaborated on their responses in free-text answers. Genetic 
counselors reported that these discussions were often preliminary, information-gathering 
discussions that guardians sometimes planned to consider in addition to separate 
discussions with other clinicians. These discussions were often complicated by the 
medical presentation of the patient and the lack of research regarding GAT’s risks and 
benefits. Without knowing how the effects of GAT could interact with the symptoms and 
risks of the child’s condition, teams were not prepared to advise families about the utility 









Table 3. Summary of GAT counseling sessions of eight genetic counselors 
























Profound intellectual and physical 
disability 6 3 0 1 5 
Profound intellectual disability 2 0 1 0 1 
Condition with variable intellectual 
and physical disability 2 0 0 1 1 
Overgrowth disorder 2 1 0 0 2 
 
Fifty-six respondents answered questions regarding their attitude and beliefs 
surrounding how GAT is addressed in the clinical setting (Table 4). Genetic counselors 
were split on whether GAT is appropriate for children with profound disability, as well as 
their level of discomfort counseling families about the intervention given the ethical 
concerns. Nearly all genetic counselors reported some level of discomfort counseling 
families about GAT due to their limited knowledge about the intervention. A minority of 
respondents felt that GAT should be offered to all guardians of children with profound 
disability. Most genetic counselors were at a minimum willing to talk to families about 
the option of GAT, but five reported that it is not something they would discuss, no 
matter the circumstances. Most genetic counselors would feel it important to make 
guardians aware of the ethical concerns surrounding GAT. Regarding the final decision 
about pursuing GAT, most respondents were supportive of a child’s guardians making 
the final decision about whether to pursue, followed by an ethics committee. Genetic 
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counselors were least supportive of the medical team making the final decision about 
whether to pursue GAT. 
Table 4. Opinion on GAT practice (all respondents) 
      
Practice Statements Strongly Disagree Disagree Neutral Agree Strongly Agree 
GAT for children with profound 
disability is not appropriate. 8 (14.3%) 19 (33.9%) 18 (32.1%) 8 (14.3%) 3 (5.4%) 
I would feel discomfort counseling a 
family about the option of GAT due 
to the ethical concerns. 5 (8.9%) 14 (25.0%) 11 (19.6%) 19 (33.9%) 7 (12.5%) 
I would feel discomfort counseling a 
family about the option of GAT due 
to my limited knowledge about GAT. 0 (0.0%) 4 (7.1%) 6 (10.7%) 20 (35.7%) 26 (46.4%) 
I would not discuss the option of 
GAT with a family, no matter the 
circumstances. 22 (39.3%) 22 (39.3%) 7 (12.5%) 1 (1.8%) 4 (7.1%) 
If a guardian brought up the option of 
GAT in a session, I would express to 
them the ethical concerns associated 
with its use. 2 (3.6%) 5 (8.9%) 6 (10.7%) 29 (51.8%) 14 (25.0%) 
GAT should be routinely offered to 
guardians of children with profound 
disability, not just discussed when 
raised by a guardian. 9 (16.1%) 12 (21.4%) 23 (41.1%) 9 (16.1%) 3 (5.4%) 
The final decision on whether GAT is 
appropriate for a child with profound 
disability should be made by the 
child's medical team. 7 (12.5%) 11 (19.6%) 22 (39.3%) 14 (25.0%) 2 (3.6%) 
The final decision on whether GAT is 
appropriate for a child with profound 
disability should be made by an ethics 
committee. 4 (7.1%) 8 (14.3%) 20 (35.7%) 18 (32.1%) 6 (10.7%) 
The final decision on whether GAT is 
appropriate for a child with profound 
disability should be made by the 
child's parents/guardians. 1 (1.8%) 6 (10.7%) 18 (32.1%) 26 (46.4%) 5 (8.9%) 
 
Interview Participants 
 Between survey respondents and participants recruited at genetics conferences, 
eight genetic counselors with experience considering GAT for a child were interviewed. 
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Six of the genetic counselors had first heard of GAT from a patient’s guardian, one had 
first heard about it in the news, and one had it first heard about it when it was brought up 
in an ethics committee meeting. All interviewees reported that when GAT was brought 
up in a clinical session, it was by guardians who were in the initial stages of exploring the 
intervention as an option, and to their knowledge, none of the guardians pursued GAT 
after speaking to the genetic counselor and their team. Indications represented included 
profound intellectual and physical disability, an overgrowth syndrome, and various 
conditions whose presentation differs between individuals, designated “variable” for the 
purposes of this study. 
Initial Reactions and Changing Perspectives 
 Interviewees shared that when GAT was first brought up, they were surprised by 
the option and felt they had to do additional research to understand it and address it with 
families. Most felt unprepared to engage guardians in a discussion about GAT. Both 
supportive and oppositional attitudes were represented in initial reactions.  
 
“I actually felt like for practical reasons I could be supportive of the therapy, just 
because I know how difficult it was for these families and caring for all the activities of 
daily living for their living. And I knew they were going to get bigger and the parents 
were going to get older and it was just going to become more and more challenging to 





“I think (I felt) surprise, initially, but also recognition of I suppose how it would be 
helpful.  But I tend to look at it as, "Well, there are lots of things that could be helpful but 
still aren't right to do” (Genetic counselor 7; Indication: variable intellectual and physical 
disability) 
 
  For some genetic counselors, their attitude toward GAT has shifted over time as 
they did more research on the topic. Shifts toward a more positive perception of GAT and 
a more negative perception of GAT were both represented. Some who initially 
appreciated the proposed benefits of GAT became more ambivalent or negative toward 
the intervention after learning about the lack of research supporting its benefits or 
concerns regarding the children’s best interests and autonomy. 
 
“When I first saw it before actually reading into it and spending some time to think about 
it I'm like oh, this could be potentially very beneficial…But my perspective definitely has 
changed a little bit since my first Google search about it. I am definitely more against 
than for it…who is our patient is the big question that kind of opened my eyes a little bit.” 
(Genetic counselor 1; Indication: variable intellectual disability) 
 
 Participants whose attitudes grew more positive over time reported feeling more 
ambivalent about the intervention, and that its appropriateness depends on the 
circumstances of the child and family. 
“Initially, I kind of questioned it, and it took me a little bit to kind of process exactly how 
I felt about it just because I think as genetic counselors we have a tendency to think not 
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just about the practical side of therapies but the ethical side as well and how it's going to 
impact the patient's well-being…now I think it really comes down to getting to know the 
family and in particular the patient and seeing kind of where they're at depending on 
where they're at developmentally and where their physical abilities are and exactly what 
the struggles are with their guardians as far as would this really be the best thing for the 
well-being of the patient.” (Genetic counselor 3; Indication: variable intellectual and 
physical disability) 
 
 These genetic counselors reacted differently toward discussing GAT the first time 
they heard it than they would in the future, needing time to process and reflect on what 
GAT means and its implications for their patients. 
Addressing GAT in a Session 
 None of the genetic counselors interviewed felt comfortable coordinating a 
referral to an endocrinologist. Reasons for this included an opposition to GAT itself, 
feeling that discussing GAT was outside a genetic counselor’s purview, and the specific 
patient’s indication (e.g., child was older than recommended for GAT, child had only 
minor intellectual disability). There were three primary responses genetic counselors and 
their teams gave to guardians considering GAT for their child: defer to a physician, 
verbally oppose, or offer psychosocial counseling. 
 Some genetic counselors shared that they often immediately defer questions about 




“(I) defer to my medical team.  In the moment, I'm not sure if I would get into it, but it's 
pretty common for me to get questions about medical management that I just bounce 
right back to the medical team because I don't deal with any of that. I get a little bit 
sheltered in my genetic counseling role.” (Genetic counselor 7; Indication: variable 
intellectual and physical disability) 
 
 Typically with input from a physician, some teams declined to discuss GAT due 
to the ethical concerns. 
 
“(The doctor) was very much like, “It's not something that I can prescribe.” He's like, “I 
don't recommend it, especially for (this indication), just all the ethical concerns around 
it… I wasn't quite as blunt…I directed it more of like this really wouldn't benefit the 
patient. It's not going to prevent the symptoms.” (Genetic counselor 1; Indication: 
Variable intellectual disability) 
 
  Some of the genetic counselors who opposed GAT emphasized that it is not a 
treatment for the symptoms of physical or intellectual disability. This fact is implied by 
the goals of the intervention and has been raised indirectly by clinicians who argue that 
the intervention benefits guardians alone, but these genetic counselors presented a 
different argument. These genetic counselors were open to the possibility that there could 
be a yet unconfirmed quality of life benefit to the intervention but concentrated on the 
medical aspects of the child’s condition and found GAT inappropriate unless it could 




“We agreed that other people do this and we aren't going to say that anybody is horrible 
for doing this, but it is not treating the disorder that we are there to treat.” (Genetic 
counselor 7; Indication: variable intellectual and physical disability) 
 
  Although most genetic counselors reported that their team would simply decline 
to discuss referral for an intervention to which they are opposed, one genetic counselor 
shared that her team will refer out to other institutions for interventions that are 
unavailable or not prescribed at their own clinic. This was described as a norm of her 
institution to help clients access the interventions they seek, even if those interventions 
are not supported by the team at her institution. 
 
“…If another hospital has a different opinion on the ethics of the case and they're 
aligned with the family, then we will do everything we can to help get them to that 
organization to have that discussion internally.” (Genetic counselor 5; Indication: 
Profound intellectual and physical disability) 
 
 Interviewees also shared that although they felt unprepared or unwilling to talk 
about GAT as a feasible option at the time of the session, it is important to them to 
understand the guardians’ perspective and household struggles that led to considering 
GAT as an option, and to provide support as they face the future of caring for their child. 
Genetic counselors reasserted that within their teams, medical management questions are 
typically deferred to a physician, and the limited information surrounding GAT 
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compounds genetic counselors’ reluctance to delve deeply into its utility for a child. 
However, their training and experience working with clients facing difficult medical 
management decisions means that GCs are well-positioned to help clients considering 
GAT to develop further insights into their own values and resources.  
 
“I think I feel more comfortable kind of being supportive of them and trying to help them 
with this, just because I have seen a lot of patients and I know what the daily challenges 
are for these families…Also, I’m a parent. Maybe that helps, too. I can really relate to 
how difficult that would be to change the diaper of a 200-pound guy, you know what I 
mean?” (Genetic counselor 8; Indication: profound intellectual and physical disability) 
 
 These genetic counselors also emphasized welcoming further discussion about 
why the client is considering GAT, rather than immediately deferring to a physician or 
declining to discuss the option. They found it important to understand the context in 
which a client considers the option and to create a space in which clients taking on the 
important role of caring for an affected child can share their story and feel heard and 
respected.  
 
“I believe we have nothing to gain from closing doors on options that parents bring to us. 
I don't think that means we then need to offer the service, but we should at least be open 
to having the discussion and hearing what's led them to wish to pursue that as an 
option…We can try to make sure that to the best of our ability our patients feel heard and 
that we're not just disregarding the experience that they bring to the table in caring for 
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their child, because they know more about that child than anyone in the health care team 
and we should respect that experience.” (Genetic counselor 5; Indication: variable 
intellectual and physical disability) 
 
Although none of the interviewed genetic counselors had teams that have referred 
clients to GAT services, these participants counseled with a less directive stance in order 
to create an environment in which clients felt comfortable to share their worries and 
obstacles and felt heard by the team. 
Themes Within the Four Topics 
 Themes relating to the four topics arose in the interview when considering 
participants’ attitudes toward GAT’s utility and for whom it might be appropriate. 
Themes and subthemes are summarized below and presented with representative 
quotations in table 5.  
Medical Indications 
 When asked for which indications GAT might be appropriate, participants 
highlighted the nuance to each situation and how an objective guideline for whom GAT 
is appropriate would be impossible to establish. Generally, participants agreed that GAT 
was inappropriate if the child’s condition has the potential of improving, and that it was 
less appropriate if the child is ambulatory. Most participants supportive of GAT were 
inclined to accept the intervention in the context of a child with profound intellectual 
disability. Additionally, two genetic counselors shared their experience working with 
clients who have profound physical but no intellectual disability. Sometimes these clients 
express concerns about how their care might change as they and their caretakers age, 
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which led these genetic counselors to suggest that GAT may also be appropriate when the 
indication does not include intellectual disability. 
Quality of Life 
 Participants who opposed GAT highlighted the unproven benefits to the family or 
child. Additionally, those participants who support the intervention emphasized that more 
research must be published to confirm the proposed benefits. Suggestions included 
interviews with parents who elect or decline GAT to understand their motivations and 
goals, longitudinal studies to monitor for side effects and benefits, and assessment of 
length of home-care for children whose diagnosis includes both profound disability and 
short stature as proxies for children who complete GAT.  
Contextual Features 
When participants chose to explore the psychosocial components affecting a 
guardian’s decision to consider GAT, they typically thought about the child’s indication 
in combination with the guardian’s resources and support network. Some participants 
asserted that other strategies to relieve parenting stressors, such as access to home-care 
resources, should always be pursued first before considering GAT as an option. 
Some genetic counselors also emphasized the importance of involving disability 
advocate groups in discussions of when GAT is appropriate. These genetic counselors 
asserted that the medical community would do well to understand the perspective of these 







 Most interviewees expressed continued concern that a child with a profound 
disability cannot express their care preferences or consent to GAT, and that the 
intervention undermines the child’s autonomy. One genetic counselor emphasized that 
there is no way to know what medical advances will be developed in the future, and that 
protecting possible future autonomy is important despite any present indication. Genetic 
counselors questioned for whom the intervention was being pursued: children or their 
caregivers. For some of these genetic counselors, the decision to pursue GAT relied on 
understanding the context of the family situation to extrapolate what the child would 
want if they were able to express it. Other GCs supportive of GAT asserted that pursuing 
the intervention does not threaten the autonomy of the child because a child with a 
profound disability does not have autonomy to lose.  Regarding the four topics, patient 
preferences overlap with medical indications, particularly in the case of children able to 













Table 5. Four Topics themes, subthemes, and representative quotations  
   




guidelines based on indication 
“The more and more training that I've gotten in ethics, the more nuanced these 
issues become…where you might want to make strict guidelines based on (some 
cases), the next case comes along and throws another piece into the puzzle that 
complicates following a strict guideline.” (Genetic counselor 4; profound 
intellectual and physical disability) 
 Degree of disability 
 
 
“If you have a condition where there is an expectation that a treatment may shift 
their capacity in the future…now you go to the arguments of protecting future 
autonomy” (Genetic counselor 1; variable intellectual disability) 
 
“It…would depend on the degree of independence, right? Maybe not necessarily 
the intellectual disability, but can they do activities of daily living…It’s a 
practical question. Like, can they transfer, can they go to the bathroom, can 
they-- you know?” (Genetic counselor 8; profound intellectual and physical 
disability) 
 
 Age cutoff “Given their age (11-12), the expected effects of GAT weren’t going to be 





Unproven benefit “…doing something with known side-effects without any evidence of benefit is 
not something that I recommend.  I think it becomes very different if we have 
good evidence of a direct benefit to the patient…But lacking that, I think it's a 
lot harder sell.” (Genetic counselor 6; profound physical disability) 
 
 Further research “They could…do comparable studies looking at conditions where children just 
naturally are smaller who have very significant limitations and need (help with) 
very basic care, compared to children who are larger and/or have kind of typical 
growth…and be able to use that as maybe a starting metric to see if there is any 
real benefit in having this offered.” (Genetic counselor 4; profound intellectual 
and physical disability) 
 
“…it’d also be interesting to hear a collection of experiences, if things had gone 
through ethics committees, and the different decision-making that those ethics 
committees had gone through, and (if GAT was) ultimately being approved or 
not…how families felt about it, too, after doing it, if they decided it was 
ultimately a good idea or not. I think those would all be helpful things.” 




Indication’s impact on context “…the child had profound intellectual disabilities and in addition had severe 
seizure disorder, so would seize 20- 30 times per day…did not do any activities 
as daily living, relied on the family to do all of his care, the diapering and 
feeding and moving and transfers…” (Genetic counselor 8; profound intellectual 
and physical disability) 
 
 Caregiver context “This patient was so impaired and the mom was a single mom and having a hard 
time as she was getting older…It was just becoming more and more difficult for 
mom as she got older and as the child was growing to just move her around and 
take care of her.” (Genetic counselor 8; profound intellectual and physical 
disability) 
 
 Trying other solutions first “(GAT could be appropriate) if it’s a family where they just don’t have the 
resources to make changes in their home to help with care.” (Genetic counselor 




 Disability advocate involvement “(GAT’s proposed quality of life benefits) seem like something that would be a 
benefit to the child and then the adult. But the argument against and especially 
comments from people within the disability community certainly plays into the 
challenge of making sure that this is actually for the benefit of the child and not, 
you know, for the convenience of people caring for them.” (Genetic counselor 




Who is the client? “It may allow for the child to potentially receive better care from their 
parents…But, I guess, my biggest issue is what happens when…the parents 
aren’t around anymore…are they more prone to be taken advantage of because 
of their size?...When they're older, who is it conveniencing?” (Genetic counselor 
1; variable intellectual disability) 
 
 Protecting autonomy “Part of the argument in this is that these individuals will never have the 
capacity to make that decision for themselves due to the severity of their 
condition, but I think that would be an important consideration of maybe not 
now but in the future could their capacity change.” (Genetic counselor 4; 
profound intellectual and physical disability) 
 
 Preference if child could choose “…While it might take autonomy away for some of these children, in the long 
run, keeping them with their families, or being able to keep them more mobile 
and able to go out and about with their families…is important, and I think 
probably what, if they were able to express their needs, potentially what they 
would prefer.” (Genetic counselor 5; variable intellectual and physical 
disability) 
 
 Profoundly disabled children 
lack autonomy 
“I know there are ethical issues that come up with this, but to me the children 
unfortunately don’t have a lot of autonomy, because they’re so limited…they 
couldn’t make a decision about that and so the parents are their surrogates in 
decision-making. So, I don’t really even see a conflict between the patient’s 
autonomy and the parents’ autonomy in those such severe cases.” (Genetic 
counselor 8; profound intellectual and physical disability) 
 
Zone of Parental Discretion 
 Interviewees’ perspective on where to draw the line in parental decision-making 
aligned closely with the concept of the Zone of Parental Discretion; participants all 
asserted that guardians should make the final decision about any medical option, except 
for in the case of “clear harm.” All participants offered scenarios of clear harm or risk 
such as denying a child with a metabolic condition the diet that would prevent symptom 
development or pursuing a new and untested intervention without monitoring its effects. 
Many participants asserted that although a genetic counselor might invoke psychosocial 
counseling techniques to better understand and acknowledge a guardian’s reasoning for 
pursuing a contraindicated intervention, non-directiveness should not be maintained in 
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these instances. Instead, genetic counselors should concertedly counsel against the option 
or involve appropriate authorities such as a social worker, child protective services, or an 
ethics committee. 
 
“It should ultimately be the parents’ call. But it comes back to is there any clear harm to 
the child, for making this decision? So in a situation where there is clear harm, then I 
think that’s when it’s appropriate that, you know, potentially you need to step in and alert 
social work, or alert an ethics committee, where there’s something concerning going on 
in how this family’s caring for their child.” (Genetic counselor 6; Indication: profound 
physical disability) 
 
  Genetic counselors who compared GAT to sterilization viewed sterilization as 
more harmful, as it may be an invasive surgery and its benefits can be achieved through 
other means such as birth control. However, the perception of GAT’s harm varied. 
Genetic counselors who opposed GAT shared that the potential side effects presented 
enough risk that GAT is inappropriate to them. However, when asked to elaborate, no 
interview participants were able to list specific side effects of GAT. They instead asserted 
that because there are no rigorous studies on side effects in this population, the risk for 
unknown side effects is reason to deny access to the intervention until clear benefits are 
established.  Others perceived the risk of side effects to be low, and the potential benefit 





Guardians as Advocates and Researchers  
 A persistent theme among interviewees who were neutral toward or supported 
GAT was the concept of guardians acting as advocates and researchers to improve their 
child’s care. They emphasized that guardians do not flippantly make medical decisions 
for their children and may consider GAT only after careful deliberation. 
 
“The phrase ‘therapy of last resort’ kind of pops into my head repeatedly when I think 
about this.  I think families who are considering some of these options are at a place 
where they are really searching for something that will make a meaningful difference for 
them.  In my experience, this has not been a consideration that people have taken lightly 
at all.” (Genetic counselor 2; Indication: overgrowth syndrome) 
 
 These genetic counselors also raised the historical significance of parents 
advocating for new treatments and interventions and the benefit that advocacy has 
provided the medical community and its patients. 
 
“And so sometimes it's really the families that drive some innovation and push the 
envelope. Really this one, we were the first case report for (increasing the dose of a 
medication). That was the mom that was like, "I want to go up!" She really pushed us to 
go up on the dose. And there was no harm in it, and then it changed the whole field. So 
all the kids are getting it, and they're getting it younger now because these other families 
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pushed it.” (Genetic counselor 8; Indication: profound intellectual and physical 
disability) 
 
 Participants also reemphasized the need of many guardians to feel respected and 
heard by their medical teams. Caregivers who feel ignored or misunderstood by their 
primary clinicians may seek interventions elsewhere, for better or worse. 
 
“Many come with stories of, you know, we wanted this considered, or we had this 
concern and they felt like it wasn't given appropriate attention by their medical provider. 
A lot of things… now being offered as treatments were historically used and developed by 
parents because they felt like that need wasn't being met by the medical community.” 
(Genetic counselor 5; Indication: profound intellectual and physical disability) 
 
 These genetic counselors held respect for guardians exploring medical options as 
a tenant of their counseling style and emphasized empathy and support for guardians 
during the parenting process, even in the context of trying to persuade a guardian against 
a choice involving clear harm. 
Genetic Counselors’ Role in Ethical Decision-Making 
 All genetic counselors interviewed highlighted ways in which genetic counselors 
offer expertise in discussions of ethical decision-making. Of primary significance were 
genetic counselors’ psychosocial counseling skills, which allow them to explore the 
nuance of a family’s circumstance and develop a holistic understanding of a patient and 
their guardians. Although genetic counselors frequently face unique circumstances and 
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questions about interventions such as GAT about which they know little, the 
psychotherapeutic training genetic counselors receive gives them tools to productively 
discuss these options and the clients’ needs in an open and less medicalized way than a 
physician might. 
 
“Genetics deals with a bunch of the weird situations.  That is our bread and butter, is the 
unusual stuff, and honestly that's a lot of time where you find questionable things, is in 
the unusual cases, and so I think our comfort in that kind of space would be valuable. 
And I think that…having people who perhaps come from a more non-directive 
background might balance out some of the more directive MDs in the bunch.  And I feel 
like we get a lot more training and experience with talking through things, and difficult 
topics, with patients than a lot of MDs have time for.” (Genetic counselor 7; Indication: 
variable intellectual and physical disability)  
 
These skills - and the additional time that genetic counselors have to spend with 
clients - offer clients an environment in which to feel heard and understood. Genetic 
counselors also act as a bridge between the client and their care team and so can make 
sure that all voices are considered as a decision is being made. 
 
“…We’re able to see kind of both perspectives usually-- there’s the patient perspective 
and the physician-medical perspective-- I think differently than maybe the physicians do. 
And so we have such a unique opportunity…The physician probably doesn’t have time to 
hear about the day-to-day of “We’ll have to lift the child and then I have to diaper,” and 
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all this stuff, right?…People that are in the kind of day-to-day care of the patients can 
really empathize more. And so that may help us really have a better perspective on these 
bioethical conflicts that come up.” (Genetic counselor 8; Indication: profound intellectual 
and physical disability) 
 
Suggestions for Guidelines 
 Beyond the additional research interviewees recommended to further understand 
the implications of GAT, participants made suggestions for what might be useful in a 
practice guideline developed for counseling about controversial interventions such as 
GAT. Some responses mirrored those from the survey, indicating that it would be most 
valuable to have recommendations on how to elicit a narrative to better understand the 
worries and goals of a guardian considering a controversial intervention and how to help 
them think through their options. Interviewees also recommended developing a toolkit to 
help genetic counselors think about and choose appropriate ethics resources when 
appropriate. 
 
“(What would be useful is) different documents in regards to kind of ethical decision-
making, different avenues or people you might be able to contact, to help with some of 
your decision-making. You know, different structures, maybe, that people go through with 
making some of these difficult decisions, or things like that. So I think more of a toolkit 
would be more appropriate than an actual position statement.” (Genetic counselor 6; 




 Most of the interviewees reported that decisions about how to counsel were 
typically made as a team, but the weight that each team member had in making decisions 
varied. One common suggestion for a guideline was a compendium of experiences 
making difficult clinical decisions and how teams might be structured to better meet 
clinical goals, as well as the resources used to meet those goals.  Participants reported 
that having a mentor in ethics, such as an experienced genetic counselor or member of an 
ethics committee, was invaluable when facing complicated counseling cases.  Genetic 
counselors recommended that a useful guideline would also offer suggestions to develop 
and structure a peer supervision group, which can serve as a resource for difficult or 
complex cases. 
 
“(How to develop) a peer supervision group…Put in a plug for that. That's a great, great 
place to get the comments of your peers on difficult cases.” (Genetic counselor 8; 
Indication: profound intellectual and physical disability) 
 
 For many of the GCs interviewed, these are skills which were honed and 
resources that were learned over the course of clinical practice, rather than in their 
graduate programs. It is useful to know how to counsel for difficult and poorly researched 
topics and to know where one can turn in difficult situations regardless of a genetic 
counselor’s specialty or experience level., Having resources available to learn about these 




 Interviewees acknowledged that genetic counselors are not typically central to 
medical decision-making, and that a useful guideline for when it is appropriate to 
implement GAT would be best developed by or in collaboration with a larger clinical 
organization. Many suggested, however, that a guideline should include the 
recommendation to involve members of the team such as genetic counselors who can 
incorporate psychosocial counseling and the elicitation of values and goals to help 
guardians make decisions that align with their values. 
 
“I think (the guideline should include) an emphasis on the role that genetic counselors 
can play…I frequently think that genetic counselors are in a position where they may be 
the only provider who talks about issue X and you could fill in the blanks there for a lot 
of things with a particular family and…I think we all received training on things like 
anticipatory guidance. I think this falls under that rubric, you know, discussing some of 
these again, options that may be controversial or where different families may make very 
different decisions depending on their own interpretation or conceptualization of the 










This research is the first to explore clinicians’ practice beliefs and behaviors 
regarding GAT, as well as the values and priorities that contribute to their attitude toward 
this controversial intervention. The results suggest that, just as in other fields, GAT 
remains a divisive intervention to consider for children with profound disability. 
Differences in how GCs who support GAT and GCs who oppose GAT rank arguments 
for or against the practice reveal that although all GCs’ primary concern is the well-being 
of the child, they interpret the benefits, risks, and psychosocial consequences of GAT 
differently.  Two primary differences that arose were that GCs opposing GAT emphasize 
children’s inability to consent to GAT and its potential to infantilize patients, while those 
who support GAT believe that guardians have the right to make decisions for their child – 
or that children with profound disability do not have autonomy to infringe upon – and 
treating patients by their cognitive age is not infantilization. These differences in core 
beliefs are not likely to be resolved with further debate or discussion. Some respondents 
reported that their attitude toward GAT may shift toward supporting if GAT’s proposed 
benefits are confirmed but concerns about autonomy and infantilization will not be 
eliminated even if quality of life improvements are verified. It is likely that the debate 
surrounding these factors will persist even if data ultimately support GAT’s proposed 
benefits.  
Practice beliefs also vary. Similar to Wrigely and colleagues’ 2017 study of New 
Zealand medical professionals, nearly the same proportion of genetic counselors believed 
GAT should be offered routinely to guardians of children with profound disability as 
those who reported they would never discuss the option of GAT with a guardian. 
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However, both groups were in the minority. Although nearly a third of genetic counselors 
personally opposed GAT, most respondents agreed that the intervention may be 
appropriate in certain circumstances.  
The survey text responses and interviews revealed that, for many genetic 
counselors, the limiting factor for genetic counselors to support GAT clinically is proof 
of its risks and benefits. Genetic counselors made suggestions for further research which 
could support or dismiss the possible benefits GAT offers to patients and their families.  
Given the lack of known clinical utility of GAT in genetics at this time, GCs 
emphasized the value that GCs offer in providing therapeutic support to guardians who 
struggle with caring for their child. Although GCs may not be able to provide education 
about GAT and rarely do their teams offer to refer to an endocrinologist, GCs have the 
training to help guardians explore their needs, support resources, and sources of resilience 
as they face the future of caring for a child with a profound disability. GCs did suggest, 
however, that the field would benefit from guidelines to help GCs frame these counseling 
discussions to best benefit the guardians. Respondents also suggested the development of 
a toolkit to help GCs find and access resources such as an ethics committee or peer 
supervision group to support their work when they face difficult or ethically challenging 
cases. Notably, NSGC provides peer supervision resources as well as ethics consultation 
services to its members. It may be that these resources are not well known or 
underutilized by genetic counselors. 
  The genetic counselors surveyed and interviewed for this study consider medical 
decisions and parental decision-making in ways that align closely with the Four Topics 
approach and the Zone of Parental Discretion. Becoming familiar with these tools may be 
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useful for genetic counselors and other clinicians to better understand and articulate their 
own methods for considering these topics, as well as to present frameworks for use 
institutionally or within their teams. 
 
Study Limitations 
 This study was limited by a low response rate, which restricted quantitative 
analysis to descriptive statistics. There are further analyses that could have practice 
implications, such as understanding whether experience with GAT, knowledge of GAT, 
or demographic characteristics impact one’s attitude toward the intervention, or if genetic 
counselors with different attitudes toward GAT have statistically significant differences 
in how they address it in clinic. It is also possible that the content of the survey attracted 
genetic counselors with knowledge of or experience with GAT, skewing understanding of 
GAT knowledge or how often GAT is raised in genetic counseling sessions.  
 The interviews were similarly affected by low numbers. Although they offered a 
more detailed and holistic understanding of the beliefs and practices of genetic counselors 
GAT discussions, saturation was not reached for the great majority of themes. Seven of 
the eight genetic counselors who reported clinical discussions of GAT on the survey were 
interviewed. However, the survey indicated that there are clinics in which GAT 
discussions are initiated by clinicians, and no genetic counselors from such clinics 
volunteered to be interviewed. It is also likely that as more genetic counselors counsel 
guardians about GAT, more diverse responses and considerations will develop. 
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 Responses to survey and interview questions were subject to participants’ 
interpretation of what a GAT counseling session might entail and their own role as a 
genetic counselor. The study identified two primary perceptions of a genetic counselor’s 
role in GAT counseling: either little to no role, because questions about GAT are highly 
medical and more appropriate for a physician to answer, or as a psychotherapeutic 
resource to the guardians considering GAT for their child. It is possible that there were 
respondents who theoretically subscribe to one of these perceptions, but in practice act on 
the other. Several survey participants directly questioned the role of a genetic counselor 
in any GAT discussion using the free text responses. It may be that this question arose in 
the medical and ethical context of the survey, but in practice a portion of these genetic 
counselors would use the counseling techniques described by some of the interview 
participants to engage in the GAT discussion if confronted by that in an actual clinical 
encounter. From the interviews it is clear that there are some genetic counselors who do 
not engage or only minimally engage in these discussions, but the frequency of this 
practice in comparison to therapeutic counseling is unclear.  
This study offered a cross-sectional understanding of the attitudes of a subset of 
pediatric genetic counselors, most of which reported little to no knowledge of GAT 
before taking the survey. It is possible – even likely – that the beliefs respondents hold 
toward GAT will change as they learn more about it, experience discussions in their 
clinic, or as further research regarding its risks and benefits are published.  
Practice Implications 
 These data suggest that although growth attenuation therapy is rarely brought up 
in genetic counseling sessions, when it is brought up it is often in the context of guardians 
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looking for a solution and support during a difficult time caretaking. Few genetic 
counselors feel they have the knowledge of GAT or medical expertise to counsel 
regarding the utility of the intervention, but many acknowledge genetic counselors’ 
expertise in providing psychosocial counseling to better understand the stressors 
guardians face as they think about GAT as an option and to provide support as guardians 
care for their children.  
 Survey responses indicate that a minority of genetic counselors are aware of GAT 
as an option for children with profound disability, which introduces a risk of genetic 
counselors being surprised by the suggestion and unable to offer support when a guardian 
brings it up in clinic. Both survey and interview responses included those from genetic 
counselors who would decline or have declined to talk about GAT in a session beyond 
letting a guardian know that it won’t be offered by their institution. Genetic counselors 
are unlikely to stay abreast of all medical options available to guardians, and to counsel 
about their utility is considered outside their purview for many genetic counselors. 
However, genetic counselors should be prepared to offer psychosocial support and 
counseling when guardians are considering care options for their child, whether the 
genetic counselor is familiar with or supportive of the options being considered. It may 
be that additional educational offerings from NSGC for each new procedure is not 
feasible, but resources to prepare genetic counselors for the psychotherapeutic role of 
discussing difficult options can help genetic counselors feel more prepared. 
Research Implications 
 This study assesses the reactions toward GAT of clinicians who are on the 
periphery of the GAT debate and GAT decision-making. Although genetic counselors are 
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involved in diagnosis and continued care of children with profound disability, they are 
rarely involved in medical management decision-making. Genetic counselors’ value as 
therapeutic counselors and as the bridge between client families and physicians can prove 
important when guardians are considering a controversial intervention option for their 
child, but it is not genetic counselors’ opinion on GAT that is likely to shape the GAT 
debate or its use in the future.  
 To better understand the state of GAT’s use now, over ten years after Gunther and 
Diekema’s first report, a study of endocrinologists’ attitudes and practice beliefs is 
recommended. Endocrinologists are at the forefront of GAT implementation and could 
offer insight into how institutions choose for whom GAT is appropriate and how or when 
resources such as ethics committees are used. It is unclear if GAT practice aligns with 
recommendations from Wilfond and colleagues’ working group guidelines or if there is 
any consistency to its use, and such a study has the potential to reveal the significant 
subjectivity to its use implied by the present study. 
 There is an overt gap in the GAT literature regarding guardian experiences 
making decisions about the intervention. There are isolated cases of parents sharing their 
stories and case reports of parents who choose to pursue GAT, but no published studies 
that synthesize the experiences of a large population of guardians who have considered 
GAT, the thought processes through which they choose to pursue or decline the 
intervention, or the outcomes of their decision. Pollock and colleague’s 2015 study of 
American endocrinologists reported that nearly 30 physicians claimed to have prescribed 
GAT to at least one patient. Understanding the guardians’ decision-making process and 
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the process by which other guardians choose to decline GAT will provide important 
context to the GAT discussion which is currently absent. 
 Interviewees offered suggestions for further research to better illustrate the risks 
and benefits of GAT for children with profound disability. GAT has now been prescribed 
for over ten years, but there have been no reports published to summarize the side effects 
that have developed in this population and there are no known projects in place to follow 
patients or controls longitudinally to better understand quality of life benefits. As 
suggested by one interviewee, a proxy for this study would be to assess differences in 
years of care at home between children with profound disability and short stature 














Pediatric genetic counselors often counsel guardians about diagnosis and 
prognosis for their child, but rarely do guardians engage them in discussions of GAT as 
an option to facilitate care. Although genetic counselors largely believe that their role is 
to offer support and anticipatory guidance to guardians who share the difficulties they 
face raising a child, many are uncomfortable discussing GAT due to their lack of 
knowledge of GAT, lack of involvement in medical management decisions, or opposition 
to the intervention. Until there is clear evidence to support or reject GAT’s utility for 
children with profound disability, genetic counselors should continue to cultivate the 
skills to offer accurate empathy and therapeutic counseling for clients who are facing 
difficult decisions or obstacles. The development of professional resources to guide 
genetic counselors as they counsel on controversial topics or face challenging ethical 
cases will benefit both the genetic counseling field and the clients it serves. 
ACKNOWLEDGEMENTS 
 This research was supported by the Intramural Research Program of the National 









Allen, D. B., Kappy, M., Diekema, D., & Fost, N. (2009). Growth-attenuation therapy: 
Principles for practice. Pediatrics, 123(6), 1556-1561.  
Beauchamp, J. (2013). "Principles of Biomedical Ethics". Principles of Biomedical 
Ethics. 
Bersani, H., Rotholz, D. A., Eidelman, S. M., Pierson, J. L., Bradley, V. J., Gomez, S. C., 
et al. (2007). Unjustifiable non-therapy: Response to the issue of growth attenuation 
for young people on the basis of disability. Intellectual and Developmental 
Disabilities, 45(5), 351-353. 
Brosco, J. P., & Feudtner, C. (2006). Growth attenuation: A diminutive solution to a 
daunting problem. Archives of Pediatrics & Adolescent Medicine, 160(10), 1077-
1078. 
Burke, B. M. (1992). Genetic counselor attitudes towards fetal sex identification and 
selective abortion. Social Science & Medicine, 34(11), 1263-1269. 
Clarke, A. (2017). The evolving concept of non-directiveness in genetic counselling. In 
History of Human Genetics (pp. 541-566). Springer, Cham. 
Committee on Bioethics. (1999). Sterilization of minors with developmental 
disabilities. Pediatrics, 104(2), 337-340. 
Cureton, A., & Silvers, A. (2017, September). Respecting the dignity of children with 
disabilities in clinical practice. In HEC Forum (Vol. 29, No. 3, pp. 257-276). 
Springer Netherlands. 
Diekema, D. S., & Fost, N. (2010). Ashley revisited: a response to the critics. The 
American Journal of Bioethics, 10(1), 30-44. 
Gillam, L. (2016). The zone of parental discretion: An ethical tool for dealing with 
disagreement between parents and doctors about medical treatment for a child. 
Clinical Ethics, 11(1), 1-8. 
Gunther, D. F., & Diekema, D. S. (2006). Attenuating growth in children with profound 
developmental disability: A new approach to an old dilemma. Archives of Pediatrics 
& Adolescent Medicine, 160(10), 1013-1017.  
Kuperberg, M., Lev, D., Blumkin, L., Zerem, A., Ginsberg, M., Linder, I., Carmi, N., et 
al.  (2016). Utility of whole exome sequencing for genetic diagnosis of previously 




Morse, J. M. (1997). " Perfectly healthy, but dead": The myth of inter-rater reliability. 
Qualitative Health Research, 7(4), 445-447. 
Morse, J. M., Barrett, M., Mayan, M., Olson, K., & Spiers, J. (2002). Verification 
strategies for establishing reliability and validity in qualitative research. 
International journal of qualitative methods, 1(2), 13-22. 
National Society of Genetic Counselors. (2018). Professional status survey 2018: 
Demographics & methodology. Chicago, IL. 
Ouellette, A. R. (2007). Growth attenuation, parental choice, and the rights of disabled 
children: Lessons from the ashley X case. Hous.J.Health L.& Pol'Y, 8, 207.  
Pollock, A. J., Fost, N., & Allen, D. B. (2015). Growth attenuation therapy: Practice and 
perspectives of paediatric endocrinologists. Archives of Disease in Childhood, 
100(12), 1185.  
Pyett, P., Rayner, J., Venn, A., Bruinsma, F., Werther, G., & Lumley, J. (2005). Using 
hormone treatment to reduce the adult height of tall girls: Are women satisfied with 
the decision in later years? Social Science & Medicine, 61(8), 1629-1639. 
Schumann, J. H., & Alfandre, D. (2008). Clinical ethical decision making: The four 
topics approach. Semin Med Pract, 11, 36-42. 
Silver, R., Bernhardt, B. A., Wilfond, B., & Geller, G. (2007). Genetic counselors' 
experiences of moral value conflicts with clients. Journal of Genetic 
Counseling, 16(6), 690. 
Tan, N., & Brassington, I. (2009). Agency, duties and the “Ashley treatment”. Journal of 
Medical Ethics, 35(11), 658-661.  
Venn, A., Hosmer, T., Hosmer, D., Bruinsma, F., Jones, P., Lumley, J., et al. (2008). 
Oestrogen treatment for tall stature in girls: estimating the effect on height and the 
error in height prediction. Clinical endocrinology, 68(6), 926-929. 
Wilfond, B. S., Miller, P. S., Korfiatis, C., Diekema, D. S., Dudzinski, D. M., & Goering, 
S. (2010). Navigating growth attenuation in children with profound 
disabilities. Hastings Center Report, 40(6), 27-40. 
Wrigley, R., Kerruish, N., Hofman, P. L., Jefferies, C., Pollock, A. J., & Wheeler, B. J. 
(2017). Growth attenuation therapy for children with severe physical and cognitive 
disability: Practice and perspectives of new zealand paediatricians. Journal of 
Paediatrics and Child Health. 
Yu, Bi Liu, "Views of Genetic Counselors on the Use of PGD for Social Sex Selection 





Katherine was born in 1992 in Pennsylvania, USA. She moved to Illinois during 
childhood, where she cultivated a love for science and genetics. 
She did her undergraduate work at Miami University in Ohio, majoring in Zoology 
and Organizational Communication and co-majoring in Sustainability. During her 
undergraduate studies, Katherine worked under the direction of Drs. Nancy Solomon and 
Brian Keane to investigate the relationship between microsatellite AVPR1, vasopressin 
receptor expression, monogamy, and reproductive success in the prairie vole, as well as 
the relationship between distance, dispersal, and genetic relatedness in this species. 
 Katherine joined the Animal Programs department of Walt Disney’s Animal 
Kingdom in 2014 to further study animal behavior. There she realized her love for 
education and passion for working with people. During this time, she also volunteered as 
a group facilitator for Growth from Grief, a program to help children who are mourning 
the loss of a loved one to explore their grief in healthy, constructive, supportive ways. 
In 2016, Katherine began her ScM in Genetic Counseling with the Johns Hopkins 
University/National Human Genome Research Institute program. During her program, 
she served as a support group facilitator for the Proteus Syndrome Foundation conference 
and she interned with Concert Genetics, collecting and analyzing data to assess the use of 
race, ethnicity, and ancestry data collection across the genetic testing industry. 
